Is pelvic organ prolapse correction with vaginal mesh suitable with a correct indication and protocolized follow-up?
Submitted: 12 November 2021
Accepted: 25 January 2022
Published: 14 February 2022
Accepted: 25 January 2022
Abstract Views: 1555
PDF: 381
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Bambang Sasongko Noegroho, Akhmad Mustafa, Predictive factor for successful retrograde ureteral stent insertion in obstructive uropathy due to advanced cervical cancer , Urogynaecologia: Vol. 31 No. 1 (2019)
- Pattaya Hengrasmee, Parit Wachasiddhisilpa, Chutimon Asumpinwong, Pichai Leerasiri, Outcomes of colpectomy for uterovaginal and posthysterectomy vault prolapse: A comparative study between normal and overweight women , Urogynaecologia: Vol. 31 No. 1 (2019)
- Daniele Porru, Enrica Bucchioni, Marcello Macchi, Fabio Leva, Alberto Parmigiani, Davide Barletta, Dimitrios Choussos, Barbara Gardella, Maria Diletta Daccò, Rossella Elena Nappi, Massimo Allegri, Carlo Maria Bianchi, Arsenio Spinillo, Bruno Rovereto, Explorative study on the use of omalizumab in patients suffering from interstitial cystitis/bladder pain syndrome , Urogynaecologia: Vol. 26 No. 1 (2012)
You may also start an advanced similarity search for this article.